Working… Menu

Efficacy & Safety of RPh201 Treatment in Patients With Previous Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03547206
Recruitment Status : Terminated (Terminated by Sponsor)
First Posted : June 6, 2018
Last Update Posted : October 12, 2020
Information provided by (Responsible Party):
Regenera Pharma Ltd

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : September 27, 2020
Actual Study Completion Date : September 27, 2020